Skip to main
IRTC

iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Technologies (IRTC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 46%
Buy 46%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

iRhythm Holdings is in a strong position for sustained growth with their successful acquisitions and expected potential for expanding margins and reaching a high stock price. As their proprietary platform becomes the standard for outpatient cardiac monitoring and they continue to expand into other markets, there is a strong potential for continued revenue growth. However, risks such as legal and operational challenges, as well as competition, should be monitored carefully.

Bears say

iRhythm Holdings is maintaining strong revenue and earnings growth, with expected continued improvement due to continued scale and disciplined expense management. Despite a recent FDA clearance for their Gen 3 algorithm, it will not be implemented until 1H27, limiting its potential impact on cutting technician review time. Additionally, while the company's top priority is its Zio MCT device, it has faced delays and challenges with FDA submission and addressing cybersecurity concerns.

iRhythm Technologies (IRTC) has been analyzed by 13 analysts, with a consensus rating of Buy. 46% of analysts recommend a Strong Buy, 46% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About iRhythm Technologies (IRTC) Forecast

Analysts have given iRhythm Technologies (IRTC) a Buy based on their latest research and market trends.

According to 13 analysts, iRhythm Technologies (IRTC) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $173.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $173.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

iRhythm Technologies (IRTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.